Urologix Inc (ULGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2014 | 06-2013 | 06-2012 | 06-2011 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,608 | -4,292 | -4,695 | -3,733 | -2,169 |
| Depreciation Amortization | 587 | 674 | 695 | 565 | 793 |
| Income taxes - deferred | -36 | 1 | 35 | N/A | N/A |
| Accounts receivable | 620 | 23 | -740 | 66 | 80 |
| Accounts payable and accrued liabilities | 264 | 1,760 | 2,635 | 307 | -28 |
| Other Working Capital | 1,163 | 1,092 | 2,440 | 463 | -368 |
| Other Operating Activity | 3,480 | -1,217 | -1,083 | -38 | 437 |
| Operating Cash Flow | $-1,530 | $-1,959 | $-713 | $-2,370 | $-1,255 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32 | -79 | -57 | -272 | -81 |
| Net Acquisitions | N/A | -1,368 | -500 | N/A | N/A |
| Purchase Sale Intangibles | -10 | -32 | N/A | N/A | N/A |
| Other Investing Activity | -10 | -32 | -8 | -3 | -4 |
| Investing Cash Flow | $-42 | $-1,479 | $-565 | $-275 | $-85 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 3,829 | 116 | 4 | 10 |
| Financing Cash Flow | $N/A | $3,829 | $116 | $4 | $10 |
| Beginning Cash Position | 2,290 | 1,899 | 3,061 | 5,702 | 7,032 |
| End Cash Position | 718 | 2,290 | 1,899 | 3,061 | 5,702 |
| Net Cash Flow | $-1,572 | $391 | $-1,162 | $-2,641 | $-1,330 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,530 | -1,959 | -713 | -2,370 | -1,255 |
| Capital Expenditure | -32 | -79 | -57 | -272 | -81 |
| Free Cash Flow | -1,562 | -2,038 | -770 | -2,642 | -1,336 |